EPTIFIBATIDE STRIDES

Main information

  • Trade name:
  • EPTIFIBATIDE STRIDES Solution for injection 2MG/ML
  • Dosage:
  • 2MG/ML
  • Pharmaceutical form:
  • Solution for injection
  • Administration route:
  • Intravenous use
  • Units in package:
  • 1X10ML Vial
  • Prescription type:
  • on prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EPTIFIBATIDE STRIDES Solution for injection 2MG/ML
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Eptifibatide
  • Product summary:
  • INJ SOL 1X10MLX2MG/ML

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • B - medicinal product after change, may be placed on the market
  • Authorization number:
  • 16/ 164/14-C
  • Last update:
  • 23-11-2016

There are no safety alerts related to this product.

31-10-2018

Integrilin (GlaxoSmithKline (Ireland) Limited)

Integrilin (GlaxoSmithKline (Ireland) Limited)

Integrilin (Active substance: Eptifibatide) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)7340 of Wed, 31 Oct 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/230/T/79

Europe -DG Health and Food Safety